Approval · Notice of Compliance 29635 · 2022
PAXLOVID: Notice of Compliance 29635
Issued September 26, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29635
- Date
- September 26, 2022
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Extension of drug producdt shelf life
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PAXLOVID | Not yet assigned | — |
Medicinal ingredients
- RITONAVIR 100 MG per TAB
- NIRMATRELVIR 150 MG per TAB